Groundswell : Preparing for Internal Climate Migration

This report, which focuses on three regions—Sub-Saharan Africa, South Asia, and Latin America that together represent 55 percent of the developing world’s population—finds that climate change will push tens of millions of people to migrate within their countries by 2050. It projects that without concrete climate and development action, just over 143 million people—or around 2.8 percent of the population of these three regions—could be forced to move within their own countries to escape the slow-onset impacts of climate change. They will migrate from less viable areas with lower water availability and crop productivity and from areas affected by rising sea level and storm surges. The poorest and most climate vulnerable areas will be hardest hit. These trends, alongside the emergence of “hotspots” of climate in- and out-migration, will have major implications for climate-sensitive sectors and for the adequacy of infrastructure and social support systems. The report finds that internal climate migration will likely rise through 2050 and then accelerate unless there are significant cuts in greenhouse gas emissions and robust development action

Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson’s disease (PD) and Alzheimer’s disease (AD) versus controls. We demonstrate that the two diseases share the same protective association at the HLA locus. HLA-specific fine-mapping showed that hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1*04:07, and intermediary with HLA-DRB1*04:01 and HLA-DRB1*04:03. The same signal was associated with decreased neurofibrillary tangles in postmortem brains and was associated with reduced tau levels in cerebrospinal fluid and to a lower extent with increased Aβ42. Protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone tau PHF6 sequence, however only when acetylated at a lysine (K311), a common posttranslational modification central to tau aggregation. An HLA-DRB1*04-mediated adaptive immune response decreases PD and AD risks, potentially by acting against tau, offering the possibility of therapeutic avenues

The effectiveness of environmental policies on reducing deforestation in the Brazilian Amazon

Preserving forests is important in the fight against climate change. Indigenous peoples tend to be good stewards of forests so that they can be preserved for future generations. This research covers whether the policy of providing indigenous communities with land titles saves forests, using impact evaluation to compare 150 indigenous communities living on 400,000 km2 of rainforest (or 8 percent of the Legal Amazon) with and without land titles. When comparing indigenous communities with and without land titles, the difference between both groups is small. The reason for this finding is that remote indigenous territories are not yet threatened by deforestation and therefore do not show a significant difference between both groups. However, satellite images clearly show that some indigenous territories can act as a buffer against deforestation

Calcium isotope fractionation during coccolith formation in Emiliania huxleyi: Independence of growth and calcification rate

[1] Recently, calcium isotope fractionation in the coccolithophore Emiliania huxleyi was shown to exhibit a significant temperature dependency. An important subsequent question in this context is whether the observed fractionation patterns are caused by temperature itself or related growth rate changes. In order to separate growth and calcification rate effects from direct temperature effects, batch culture experiments with the coccolithophore E. huxleyi were conducted under varying light intensities. Despite large changes in cellular growth and calcification rates, calcium isotope fractionation remained constant. Independence of calcium isotope fractionation on growth and calcification was also obtained in two additional sets of experiments in which growth rates changed in response to varying calcium concentration and seawater salinity. These experiments also showed no direct effects of calcium concentration and salinity on calcium isotope fractionation. Values for calcium isotope fractionation of E. huxleyi coccoliths fell within a range of −1.0 to −1.6 (1000 lnα), confirming earlier results. This range is similar to that observed in several foraminiferal species and coccolith oozes, suggesting a rather homogeneous calcium isotopic composition in marine biogenic calcite. Our data further show that the calcium isotope fractionation does not change with changing isotopic composition of seawater. This is a basic requirement for reconstructing the calcium isotopic composition of the ocean over time

Cellular calcium pathways and isotope fractionation in Emiliania huxleyi

The marine calcifying algae Emiliania huxleyi (coccolithophores) was grown in laboratory cultures under varying conditions with respect to the environmental parameters of temperature and carbonate ion concentration [CO32-] concentration. The Ca isotope composition of E. huxleyi's coccoliths reveals new insights into fractionation processes during biomineralization. The temperature-dependent Ca isotope fractionation resembles previous calibrations of inorganic and biogenic calcite and aragonite. Unlike inorganically precipitated calcite, the [CO32-] concentration of the medium has no significant effect on the Ca isotope composition of the coccoliths. These results indicate a decoupling of the chemical properties of the bulk medium and the calcifying vesicle. Cellular Ca pathways of E. huxleyi indicate that fractionation cannot occur at the crystal surface, as occurs during inorganic precipitation. The dominant processes leading to the observed Ca isotope fractionation pattern in E. huxleyi are most likely the dehydration of the Ca aquocomplex at the plasma membrane and the attachment of dissolved Ca to proteins of Ca channels. The independence of Ca isotope fractionation from [CO32-] and the small temperature dependence of E. huxleyi are also important for defining the isotopic signature of the oceanic Ca sink. Since coccolithophores contribute to about half the global CaCO3 production, a relatively uniform isotopic composition of the oceanic Ca sink is further supported

A load frame for in situ tomography at PETRA III

A load frame for in situ mechanical testing is developed for the microtomography end stations at the imaging beamline P05 and the high-energy material science beamline P07 of PETRA III at DESY, both operated by the Helmholtz- Zentrum Geesthacht. The load frame is fully integrated into the beamline control system and can be controlled via a feedback loop. All relevant parameters (load, displacement, temperature, etc.) are continuously logged. It can be operated in compression or tensile mode applying forces of up to 1 kN and is compatible with all contrast modalities available at IBL and HEMS i.e. conventional attenuation contrast, propagation based phase contrast and differential phase contrast using a grating interferometer. The modularity and flexibility of the load frame allows conducting a wide range of experiments. E.g. compression tests to understand the failure mechanisms in biodegradable implants in rat bone or to investigate the mechanics and kinematics of the tessellated cartilage skeleton of sharks and rays, or tensile tests to illuminate the structure-property relationship in poplar tension wood or to visualize the 3D deformation of the tendonbone insertion. We present recent results from the experiments described including machine-learning driven volume segmentation and digital volume correlation of load tomography sequences

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

Abstract Background About half of AML patients achieving complete remission (CR) display measurable residual disease (MRD) and eventually relapse. FLYSYN is an Fc-optimized antibody for eradication of MRD directed to FLT3/CD135, which is abundantly expressed on AML cells. Methods This first-in-human, open-label, single-arm, multicenter trial included AML patients in CR with persisting or increasing MRD and evaluated safety/tolerability, pharmacokinetics and preliminary efficacy of FLYSYN at different dose levels administered intravenously (cohort 1–5: single dose of 0.5 mg/m2, 1.5 mg/m2, 5 mg/m2, 15 mg/m2, 45 mg/m2; cohort 6: 15 mg/m2 on day 1, 15 and 29). Three patients were treated per cohort except for cohorts 4 and 6, which were expanded to nine and ten patients, respectively. Primary objective was safety, and secondary efficacy objective was ≥ 1 log MRD reduction or negativity in bone marrow. Results Overall, 31 patients were treated, of whom seven patients (22.6%) experienced a transient decrease in neutrophil count (two grade 3, others ≤ grade 2). No infusion-related reaction or dose-limiting toxicity was observed. Adverse events (AEs) were mostly mild to moderate, with the most frequent AEs being hematologic events and laboratory abnormalities. Response per predefined criteria was documented in 35% of patients, and two patients maintained MRD negativity until end of study. Application of 45 mg/m2 FLYSYN as single or cumulative dose achieved objective responses in 46% of patients, whereas 28% responded at lower doses. Conclusions FLYSYN monotherapy is safe and well-tolerated in AML patients with MRD. Early efficacy data are promising and warrant further evaluation in an up-coming phase II trial. Trial registration This clinical is registered on clinicaltrials.gov (NCT02789254)